82 related articles for article (PubMed ID: 24569305)
1. Prospective validation of a risk prediction model for severe sepsis in children with cancer and high-risk febrile neutropenia.
Santolaya ME; Alvarez AM; Avilés CL; Becker A; Venegas M; O'Ryan M; Salgado C; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; de la Maza V; Vergara A; Farfán MJ; Torres JP
Pediatr Infect Dis J; 2013 Dec; 32(12):1318-23. PubMed ID: 24569305
[TBL] [Abstract][Full Text] [Related]
2. Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial.
Santolaya ME; Alvarez AM; Aviles CL; Becker A; King A; Mosso C; O'Ryan M; Paya E; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
Pediatr Infect Dis J; 2008 Jun; 27(6):538-43. PubMed ID: 18458649
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
4. Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department.
Lynn JJ; Chen KF; Weng YM; Chiu TF
Hematol Oncol; 2013 Dec; 31(4):189-96. PubMed ID: 23303687
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia.
Santolaya ME; Alvarez AM; Avilés CL; Becker A; Cofré J; Enríquez N; O'Ryan M; Payá E; Salgado C; Silva P; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
Clin Infect Dis; 2002 Sep; 35(6):678-83. PubMed ID: 12203164
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of bacteremia in febrile neutropenic episodes in children with cancer: microbiologic and molecular approach.
Santolaya ME; Farfán MJ; De La Maza V; Cociña M; Santelices F; Alvarez AM; Avilés CL; Becker A; O'Ryan M; Román P; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; Torres JP
Pediatr Infect Dis J; 2011 Nov; 30(11):957-61. PubMed ID: 21768922
[TBL] [Abstract][Full Text] [Related]
7. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia.
Lehrnbecher T; Venzon D; de Haas M; Chanock SJ; Kühl J
Clin Infect Dis; 1999 Aug; 29(2):414-9. PubMed ID: 10476751
[TBL] [Abstract][Full Text] [Related]
8. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia.
de Bont ES; Vellenga E; Swaanenburg JC; Fidler V; Visser-van Brummen PJ; Kamps WA
Br J Haematol; 1999 Nov; 107(2):375-80. PubMed ID: 10583227
[TBL] [Abstract][Full Text] [Related]
9. Administration Time for the First Dose of Antimicrobials in Episodes of Fever and Neutropenia in Children With Cancer.
De la Maza V; Simian D; Castro M; Torres JP; Lucero Y; Sepúlveda F; Mazquiaran S; Salazar C; Segovia L; Santolaya ME
Pediatr Infect Dis J; 2015 Oct; 34(10):1069-73. PubMed ID: 26125587
[TBL] [Abstract][Full Text] [Related]
10. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
11. Validation of risk stratification for children with febrile neutropenia in a pediatric oncology unit in India.
Das A; Trehan A; Oberoi S; Bansal D
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27860223
[TBL] [Abstract][Full Text] [Related]
12. Which Variables Are Useful for Predicting Severe Infection in Children With Febrile Neutropenia?
Delebarre M; Garnier N; Macher E; Thebaud E; Mazingue F; Leblond P; Duhamel A; Martinot A; Dubos F
J Pediatr Hematol Oncol; 2015 Nov; 37(8):e468-74. PubMed ID: 26479996
[TBL] [Abstract][Full Text] [Related]
13. Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk.
Diepold M; Noellke P; Duffner U; Kontny U; Berner R
BMC Infect Dis; 2008 Mar; 8():28. PubMed ID: 18321393
[TBL] [Abstract][Full Text] [Related]
14. Development of a simplified multivariable model to predict neutropenic complications in cancer patients undergoing chemotherapy.
Razzaghdoust A; Mofid B; Moghadam M
Support Care Cancer; 2018 Nov; 26(11):3691-3699. PubMed ID: 29736867
[TBL] [Abstract][Full Text] [Related]
15. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients.
Urbonas V; Eidukaitė A; Tamulienė I
Cytokine; 2012 Mar; 57(3):313-5. PubMed ID: 22189417
[TBL] [Abstract][Full Text] [Related]
16. Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode.
Santolaya ME; Alvarez AM; Avilés CL; Becker A; Mosso C; O'Ryan M; Payá E; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
Pediatr Infect Dis J; 2007 Sep; 26(9):794-8. PubMed ID: 17721373
[TBL] [Abstract][Full Text] [Related]
17. Significance of interleukin-6 (IL-6) and C-reactive protein (CRP) in children and young adults with febrile neutropenia during chemotherapy for cancer: a prospective study.
Chaudhary N; Kosaraju K; Bhat K; Bairy I; Borker A
J Pediatr Hematol Oncol; 2012 Nov; 34(8):617-23. PubMed ID: 22983415
[TBL] [Abstract][Full Text] [Related]
18. IL-8 predicts pediatric oncology patients with febrile neutropenia at low risk for bacteremia.
Cost CR; Stegner MM; Leonard D; Leavey P
J Pediatr Hematol Oncol; 2013 Apr; 35(3):206-11. PubMed ID: 23425997
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
[TBL] [Abstract][Full Text] [Related]
20. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
Janković B; Pasić S; Marković M; Veljković D; Milicić M
Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
